{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "marketState": "PREPRE", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "esgPopulated": false, "regularMarketChangePercent": -3.486683, "regularMarketPrice": 19930.0, "exchange": "KOE", "shortName": "OliX", "longName": "OliX Pharmaceuticals, Inc", "exchangeTimezoneName": "Asia/Seoul", "market": "kr_market", "regularMarketTime": 1683873005, "regularMarketDayHigh": 20850.0, "regularMarketDayRange": "19930.0 - 20850.0", "regularMarketDayLow": 19930.0, "regularMarketVolume": 83935, "regularMarketPreviousClose": 20650.0, "bid": 19930.0, "ask": 20000.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 20650.0, "averageDailyVolume3Month": 118131, "averageDailyVolume10Day": 53690, "fiftyTwoWeekLowChange": 3180.0, "fiftyTwoWeekLowChangePercent": 0.18985075, "fiftyTwoWeekRange": "16750.0 - 29250.0", "fiftyTwoWeekHighChange": -9320.0, "fiftyTwoWeekHighChangePercent": -0.31863248, "fiftyTwoWeekLow": 16750.0, "fiftyTwoWeekHigh": 29250.0, "earningsTimestamp": 1679050740, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "sharesOutstanding": 6505920, "fiftyDayAverage": 22279.6, "fiftyDayAverageChange": -2349.5996, "fiftyDayAverageChangePercent": -0.10545969, "twoHundredDayAverage": 21456.15, "twoHundredDayAverageChange": -1526.1504, "twoHundredDayAverageChangePercent": -0.07112881, "marketCap": 129662984192, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "prevName": "OliX Pharmaceuticals,Inc", "nameChangeDate": "2023-05-13", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1531872000000, "priceHint": 2, "regularMarketChange": -720.0, "symbol": "226950.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Ace Gwanggyo Tower1", "address2": "Suite 1014 17, Daehak 4-ro, Yeongtong-gu", "city": "Suwon-si", "zip": "16226", "country": "South Korea", "phone": "82 3 1779 8400", "fax": "82 3 1779 8499", "website": "https://www.olixpharma.com", "industry": "", "sector": "", "longBusinessSummary": "OliX Pharmaceuticals, Inc. focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases. The company's products pipeline includes OLX101A for skin scar; OLX201A for idiopathic pulmonary fibrosis; OLX301 for age-related macular degeneration; and OLX301D for subretinal fibrosis. The company has a collaboration agreement with Th\u00e9a to develop SiRNA therapeutics for ophthalmic diseases; and a research collaboration with PCI Biotech Holding ASA. OliX Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Suwon, South Korea.", "fullTimeEmployees": 69, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dong-Ki  Lee Ph.D.", "age": 50, "title": "CEO & Director", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sun-Woo  Hong Ph.D.", "age": 47, "title": "VP & Director of Research and Director", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Young Hye  Baek", "title": "Sr. Director of Legal Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Shin Young  Park Ph.D.", "title": "Exec. VP of Devel. Dept.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}